Stories from MedEsthetics

Business Education for Medical Practitioners
Visit us at medestheticsmagazine.com
Wednesday, February 4, 2015 - 14:33
Deck: Byline: Main Image: W. Grant Stevens, MD, FACS, and Eric Bachelor, MD, FACS, investigated the safety and efficacy of the CoolSculpting CoolSmooth applicator from Zeltiq for the cryolipolysis treatment of “nonpinchable” fat in the lateral thighs. A total of 40 patients underwent a 120-minute unilateral treatment with the conformable-surface applicator on one lateral thigh, with the contralateral thigh serving as the control. No, don't share this with BeautyEtcArticles: NewsArticle free tagging: ZeltiqCoolSculpting
http://medestheticsmag.com/coolsmooth-effective-treatment-lateral-thighs
Wednesday, February 4, 2015 - 14:29
Deck: Byline: Robert Langer, ScD, an M.I.T. professor and one of the foremost engineers in the world today, has joined the Scientific Advisory Board of Convoy Therapeutics. Dr. Langer has nearly 1,100 patents worldwide and has received more than 220 awards, including the Lemelson-M.I.T. Innovation Prize, Kyoto Prize, National Medal of Innovation and Technology, and the United States National Medal of Science. No, don't share this with BeautyEtcArticle free tagging: Scientific Advisory BoardArticles: News
http://medestheticsmag.com/robert-langer-scd-joins-convoy-therapeutics
Wednesday, February 4, 2015 - 14:26
Deck: Byline: At the 2015 International Master Course on Aging Skin (IMCAS) Annual World Congress, Lumenis debuted its new ResurFX laser system for nonablative fractional skin resurfacing treatments. The standalone desktop platform uses customized treatment parameters that allow providers to choose from more than 600 combinations of shape, size, density and energy delivery. The ResurFX is effective in a single pass and does not require disposables. No, don't share this with BeautyEtcArticle free tagging: fractional lasersArticles: News
http://medestheticsmag.com/lumenis-launches-nonablative-resurfx-system
Friday, January 30, 2015 - 13:25
In two independent European clinical studies, Sebacia gold microparticles were found to effectively reduce the appearance of inflammatory acne lesions. The gold and silica microparticles are placed in a suspension designed to penetrate the sebaceous follicles. When activated by the light of a hair removal laser, they create a focused photo-thermal effect that reduces the activity level of the sebaceous gland and follicle. No, don't share this with BeautyEtcArticle free tagging: clinical studiesArticles: Skin CareNews
http://medestheticsmag.com/sebacia-microparticles-successfully-treat-acne
Friday, January 30, 2015 - 13:22
Deck: Byline: Main Image: Global healthcare company Galderma has announced that Restylane Silk, the first and only dermal filler FDA-approved for lip enhancement and the treatment of perioral lines and wrinkles, is now available in the U.S. No, don't share this with BeautyEtcArticles: NewsArticle free tagging: fillersinjectables
http://medestheticsmag.com/galderma-restylane-silk-lip-and-perioral-treatments
Friday, January 30, 2015 - 13:16
Deck: Byline: Jeff Castillo, MBA, has joined lifestyle healthcare company ALPHAEON as President of the Americas. Castillo was previously divisional vice president at Abbott Medical Optics (AMO) where he focused on customer needs and market dynamics. Prior to AMO, Castillo spent 22 years at Johnson & Johnson, where he held a variety of senior commercial positions based in the U.S. and Latin America.No, don't share this with BeautyEtcArticle free tagging: AlphaeonArticles: News
http://medestheticsmag.com/alphaeon-appoints-presidents-americas-and-asia-pacific
Friday, January 23, 2015 - 12:53
Deck: Byline: Main Image: Patients who undergo sclerotherapy for reticular chest veins report high satisfaction with minimal adverse events. Daniel P. Friedmann, MD, FAAD, Mitchel P. Goldman, MD, FAAD, and Andres E. Cruz-Inigo, MD, performed a retrospective study of 12 patients who underwent a total of 14 treatment sessions with 0.25% to 0.5% sodium tetradecyl sulfate (STS) foam using a 1:4 liquid-air ratio. The patients were followed for a mean length of 3.7 years.No, don't share this with BeautyEtcArticles: NewsArticle free tagging: study
http://medestheticsmag.com/sclerotherapy-chest-veins
Thursday, January 22, 2015 - 12:21
Deck: Byline: The U.S. Food and Drug Administration (FDA) has agreed to ALPHAEON’s protocol for a Phase 3 clinical study of EVOSYAL, a botulinum toxin type A neuromodulator, for the treatment glabellar lines. In the last 12 months, ALPHAEON, a subsidiary of Strathspey Crown Holdings, submitted its investigational new drug application for EVOSYAL as well as completed enrollment in its Phase 2 study. Enrollment of the Phase 3 trial began on January 14, 2015.No, don't share this with BeautyEtcArticle free tagging: botulinum toxinFDAArticles: News
http://medestheticsmag.com/alphaeon-initiates-phase-3-evosyal-study
Thursday, January 22, 2015 - 12:17
Lynne Bulger has been appointed vice president, medical and clinical affairs of Cipher Pharmaceuticals, and will lead the clinical development and medical affairs efforts for current and new pipeline products. No, don't share this with BeautyEtcArticle free tagging: Cipher PharmaceuticalsArticles: News
http://medestheticsmag.com/cipher-appoints-new-vps
Friday, January 16, 2015 - 10:56
Deck: Byline: Main Image: Clinical research company Antria gained U.S. Food and Drug Administration (FDA) approval to begin Phase 2 trials with autologous adipose-derived stem cells (ADSC) in plastic surgery. No, don't share this with BeautyEtcArticles: NewsArticle free tagging: Food and Drug AdministrationinjectableADSC
http://medestheticsmag.com/fda-approves-antria-stem-cell-trials
Friday, January 16, 2015 - 09:57
Deck: Byline: Specialty pharmaceutical company Oculus Innovative Sciences has launched IntraDerm Pharmaceuticals, a new dermatology division that will develop and market advanced professional dermatological products in the U.S. and internationally. IntraDerm Pharmaceuticals is located in Petaluma, California, and employs a seasoned management and sales team who are well versed in the dermatology prescription markets in both the U.S. and Europe.No, don't share this with BeautyEtcArticle free tagging: IntraDerm PharmaceuticalsArticles: News
http://medestheticsmag.com/oculus-innovative-sciences-launches-dermatology-division
Friday, January 16, 2015 - 09:53
Main Image: The American Society for Dermatologic Surgery Association (ASDSA) presented its Patient Safety Hero Awards at the annual American Society of Dermatologic Surgery (ASDS) meeting in November. The awards recognize physicians who have actively promoted and protected patient safety in cosmetic medical procedures. No, don't share this with BeautyEtcArticles: NewsArticle free tagging: American Society for Dermatologic Surgery AssociationAmerican Society for Dermatologic Surgery
http://medestheticsmag.com/asdsa-and-asds-announce-award-winners
Thursday, January 8, 2015 - 13:32
Main Image: Biopharmaceutical company Revance Therapeutics announced the initiation of the Phase 2 BELMONT trial—a randomized, double-Blind, dosE ranging, active and pLacebo controlled, Multicenter study to evaluate the safety and efficacy and duration Of effect of RT002, a botuliNum toxin Type A injectable. No, don't share this with BeautyEtcArticles: NewsArticle free tagging: RT002botulinum toxininjectable
http://medestheticsmag.com/revance-therapeutics-begins-belmont-trial
Thursday, January 8, 2015 - 13:27
Deck: Byline: Main Image: Soolantra (ivermectin) Cream 1% from Galderma has been FDA-approved for the once-daily topical treatment of inflammatory lesions, bumps and pimples associated with rosacea. No, don't share this with BeautyEtcArticles: NewsArticle free tagging: GaldermaSoolantraivermectin
http://medestheticsmag.com/fda-approves-novel-rosacea-treatment
Thursday, January 8, 2015 - 13:22
Long-term dermal filler Bellafill (formerly Artefill) from Suneva Medical has received U.S. Food and Drug Administration (FDA) approval for the treatment of acne scars. In the double-blinded, randomized, placebo-controlled pivotal study, which included 10 U.S.-based clinical centers, Bellafill was shown to be safe and effective for the correction of moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 when compared to subjects treated with saline injection.No, don't share this with BeautyEtcArticle free tagging: Suneva MedicalFDAdermal...
http://medestheticsmag.com/bellafill-approved-acne-scars
Thursday, January 8, 2015 - 13:22
Deck: Byline: Long-term dermal filler Bellafill (formerly Artefill) from Suneva Medical has received U.S. Food and Drug Administration (FDA) approval for the treatment of acne scars. In the double-blinded, randomized, placebo-controlled pivotal study, which included 10 U.S.-based clinical centers, Bellafill was shown to be safe and effective for the correction of moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 when compared to subjects treated with saline injection.No, don't share this with BeautyEtcArticle free tagging: ...
http://medestheticsmag.com/bellafil-approved-acne-scars
Wednesday, December 31, 2014 - 08:55
Deck: Byline: The U.S. Food and Drug Administration (FDA) is seeking comments from manufacturers of human cell, tissue- and cellular-based products as well as physicians who work with these materials in relation to its new draft guidance document, “Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) from Adipose Tissue: Regulatory Considerations; Draft Guidance,” which contains non-binding recommendations on regulations surrounding the use and manipulation of biological materials. The draft guidance was posted on December 23, 2014.No, don't share this with...
http://medestheticsmag.com/fda-seeks-comments-manipulation-hctps
Wednesday, December 31, 2014 - 08:46
Deck: Byline: Electronic health record developer Modernizing Medicine has completed its purchase of Aesyntix Health, a California-based firm that provides billing and inventory services to healthcare professionals. In addition to the cloud-based Electronic Medical Assistant (EMA), Modernizing Medicine is now able to offer customers revenue cycle management, inventory management and a medical group purchasing organization.No, don't share this with BeautyEtcArticle free tagging: EMAbillinginventoryArticles: News
http://medestheticsmag.com/modernizing-medicine-acquires-aesyntix

Pages

Advertisement - Box 1

Advertisement - Box 2

Advertisement - Box 3

Advertisement - Box 4

Advertisement - Box 5

Advertisement - Box 6